| Followers | 1 |
| Posts | 255 |
| Boards Moderated | 0 |
| Alias Born | 02/23/2024 |
Wednesday, March 13, 2024 5:24:05 PM
Recent JAGX News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2025 09:46:54 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 12/11/2025 09:04:43 PM
- FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs • ACCESS Newswire • 12/10/2025 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2025 09:30:27 PM
- Jaguar Health Reports Approval of All Proposals at December 2025 Special Meeting of Stockholders • ACCESS Newswire • 12/08/2025 09:15:00 PM
- Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study • ACCESS Newswire • 12/02/2025 02:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/25/2025 09:36:52 PM
- Jaguar Health Secures New Patent for Crofelemer in Short Bowel Syndrome, Strengthening Global IP Position Ahead of Additional Clinical Milestones • ACCESS Newswire • 11/24/2025 02:00:00 PM
- In Support of Possible Expedited Approval Pathway for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID), Jaguar Health Submits Amended Protocol to FDA for Ongoing Placebo-Controlled Clinical Trial • ACCESS Newswire • 11/20/2025 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2025 06:36:55 PM
- Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue • ACCESS Newswire • 11/17/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 09:31:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:12 PM
- Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates • ACCESS Newswire • 11/14/2025 02:00:00 PM
- Jaguar Health Provides Recap of November 8, 2025 Presentation on Groundbreaking Results of Proof-of-Concept Study of Crofelemer for Treatment of Pediatric Intestinal Failure at NASPGHAN Annual Meeting • ACCESS Newswire • 11/13/2025 02:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/10/2025 09:31:19 PM
- Initial Groundbreaking Results of Proof-of-Concept Study of Jaguar Health's Crofelemer for Treatment of Pediatric Intestinal Failure to be Presented November 8, 2025 at North American Society for Pediatric Gastroenterology, Hepatology and Nutriti • ACCESS Newswire • 11/06/2025 02:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/28/2025 08:30:45 PM
- Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • ACCESS Newswire • 10/24/2025 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2025 08:30:13 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 10/03/2025 08:15:56 PM
One World Products (to become Isiah Enterprises) Targets December Operational Breakeven; 250,000+ Pounds of Pelletized Rubber Shipped • OWPC • Dec 10, 2025 11:24 AM
Growing Momentum Signals Opportunity as Explorers Shift Toward Production, Reveal Substantial Value • LFLRF • Dec 10, 2025 9:00 AM
Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • BLEG • Dec 10, 2025 9:00 AM
Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handheld Breath Collection Unit (BCU) Passes FCC Electronic Emissions Testing • BLO • Dec 9, 2025 8:45 AM
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival • AVAI • Dec 9, 2025 8:00 AM
Momentum Builds, Upside Appears as Mining Explorers Transition Toward Production, Unlock Major Hidden Value • B • Dec 8, 2025 9:00 AM
